Thermo Fisher Scientific (TMO) Interest & Investment Income (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Interest & Investment Income for 15 consecutive years, with $207.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Interest & Investment Income fell 30.3% year-over-year to $207.0 million; the trailing twelve-month figure through Jun 2026 stood at $932.0 million (down 7.17% YoY), and the FY2025 full-year result was $993.0 million, down 7.88% from the prior year.
• Interest & Investment Income slipped to $207.0 million in Q2 2026 per TMO's latest filing, from $233.0 million in the prior quarter.
• Across five years, Interest & Investment Income topped out at $309.0 million in Q4 2023 and bottomed at $18.0 million in Q2 2022.
• Historically, Interest & Investment Income has averaged $203.4 million across 5 years, with a median of $230.0 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Interest & Investment Income jumped 1263.64% in 2022, then sank 30.3% in 2026.
• Over 5 years, Interest & Investment Income stood at $150.0 million in 2022, then jumped by 106.0% to $309.0 million in 2023, then declined by 26.54% to $227.0 million in 2024, then rose by 13.66% to $258.0 million in 2025, then declined by 19.77% to $207.0 million in 2026.
• According to Business Quant data, Interest & Investment Income over the past three periods registered $207.0 million, $233.0 million, and $258.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.